Triton BioSystems - About the company
Triton BioSystems is a funded company based in Chelmsford (United States), founded in 2019. It operates as a Developing non-invasive targeted therapy for cancer patients. The company has 14 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Francis Medical, NxThera and Combat Medical.
Company Details
Triton BioSystems is developing non-invasive targeted therapy for cancer patients. It's targeted nano-therapeutic (TN) is a targeted anticancer therapy uses localized lethal heat to treat late-stage cancers such as breast, lung, ovarian and prostate cancers.
Key Metrics
Founded Year
2019
Location
Chelmsford, United States
Stage
Funding Raised
Ranked
9th among 14 active competitors
Similar Companies
Sign up to download Triton BioSystems' company profile
Triton BioSystems's funding and investors
Triton BioSystems is a funded company. Triton BioSystems has 1 institutional investor.
View details of Triton BioSystems's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Triton BioSystems's Competitors and alternates
Top competitors of Triton BioSystems include Francis Medical, NxThera and Combat Medical. Here is the list of Top 10 competitors of Triton BioSystems, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Francis Medical 2018, Maple Grove (United States), Series C | Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer | $157M | 56/100 | |
2nd | NxThera 2008, Maple Grove (United States), Acquired | Developer of thermal therapy for Benign Prostatic Hyperplasia(BPH) | $148M | 53/100 | |
3rd | Combat Medical 2008, Wheathampstead (United Kingdom), Series A | Manufacturer of medical device for curing bladder cancer | $4.17M | 47/100 | |
4th | Hygea Medical Technology 2013, Series D | Manufacturer of tumor minimally invasive interventional therapy and ablation systems | $120M | 34/100 | |
5th | Kaio Therapy 2012, Raleigh (United States), Seed | Developer of hyperthermia-based cancer therapeutic platform | $3.91M | - | 29/100 |
6th | MedWaves 1998, San Diego (United States), Series A | Innovative medical technology company specializing in minimally invasive therapeutic systems | $3M | 28/100 | |
7th | Developer of therapeutic technology for cancer treatment | $1.75M | 27/100 | ||
8th | Meijie Medical 2016, Xuhui (China), Unfunded | Developer of multimodal thermal physical ablation immunotherapy for tumors | - | - | 24/100 |
9th | Triton BioSystems 2019, Chelmsford (United States), Funding Raised | Developing non-invasive targeted therapy for cancer patients | - | 22/100 | |
10th | Ardens Lifescience 2026, Unfunded | Developer of bronchoscopic ablation systems for treating lung cancer tumors | - | - | 16/100 |
Looking for more details on Triton BioSystems's competitors? Click here to see the top ones
Triton BioSystems's Investments and acquisitions
Triton BioSystems has made no investments or acquisitions yet.
Reports related to Triton BioSystems
Here is the latest report on Triton BioSystems's sector:
Are you a Founder ?
FAQs about Triton BioSystems
Explore our recently published companies
- Grounded Gardens - Unfunded company
- Bsv Trust - Stellenbosch based, Unfunded company
- Essence Technologies - Nepal based, 2012 founded, Unfunded company
- Ait Soluciones - Ambato based, Unfunded company
- PW Immobilien Wolfgang B. Straer e.K - Landstuhl based, Unfunded company
- Contitude - Stockholm based, 2016 founded, Unfunded company
_1571836427887.png?format=webp&height=120&width=120)